Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
658.70
-12.6 (-1.88%)
BSENSE

Oct 09

BSE+NSE Vol: 1.69 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "658.70",
    "chg": -12.6,
    "chgp": "-1.88%",
    "dir": -1,
    "prev_price": "671.30",
    "mcapval": "6,861.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE416D01022",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "1.69 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/bliss-gvs-pharma-730684-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Surat-based Anupam Rasayan completes 1,750-cr acquisition of 48.2% in Bliss GVS Pharma",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-29 18:48:09",
        "description": "Surat-based Anupam Rasayan completes 1,750-cr acquisition of 48.2% in Bliss GVS Pharma  thehindubusinessline.com..."
      },
      {
        "title": "Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platform",
        "link": "https://news.google.com/rss/articles/CBMiiAJBVV95cUxQMzFfNEJfVWh5VWhoVld5eVktNDk4b3JQNlJuUGdpWVljV1BlbWJlcnNCZ0hLbHI5MWlacC1FemtpbjdwbUN0RGNQTFFFbWxyUTIxb0E3aEdxNy1pek1KV0JWZHd5dWpjTk1qNXpDN0c5dDNFWVpCWloyZTd5VGpZT0NmNWE4UUFMQUt5SEkxbkdsMEJjRE1IMkZFa2ItTGJKSy1aUnNFSkhtLTRZcEl0cW1ObVE0R0tMNE5uWVhOZV83dzVrWl9nNU5sUXVkUkczcVRFU2hlbEJxbnU2dFZ3V2Q4dEp3QnBqSEZoRktRdXA5bmFyT2V5NFpJQkhpbXkwTU93QTJVWks?oc=5",
        "imagepath": "",
        "date": "2026-09-29 12:07:57",
        "description": "Anupam Rasayan completes Bliss GVS deal, targets Rs 4,000-crore integrated platform  The Economic Times..."
      },
      {
        "title": "Buzzing stocks: Tata Group restructuring, Bliss GVS deal, HCLSoftware acquisition and more",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-09-29 06:05:25",
        "description": "Buzzing stocks: Tata Group restructuring, Bliss GVS deal, HCLSoftware acquisition and more  thehindubusinessline.com..."
      }
    ],
    "total": 3,
    "sid": "730684",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Oct-2026",
      "details": "Please find enclosed herewith the certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011",
      "datetime": "06-Oct-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (\"SEBI Listing Regulations\")",
      "datetime": "01-Oct-2026",
      "details": "Please find enclosed herewith the outcome of the Board Meeting held today i.e. Thursday October 01 2026 through Video Conferencing or Other Audio Visual Means.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Jul 26",
          "dt": "2026-07-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

06-Oct-2026 | Source : BSE

Please find enclosed herewith the certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ended September 30 2026.

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

06-Oct-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd

Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations")

01-Oct-2026 | Source : BSE

Please find enclosed herewith the outcome of the Board Meeting held today i.e. Thursday October 01 2026 through Video Conferencing or Other Audio Visual Means.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Bliss GVS Pharma Ltd has declared 100% dividend, ex-date: 08 Jul 26

stock-summary
SPLITS

Bliss GVS Pharma Ltd has announced 1:10 stock split, ex-date: 11 Mar 08

stock-summary
BONUS

Bliss GVS Pharma Ltd has announced 3:5 bonus issue, ex-date: 26 Sep 08

stock-summary
RIGHTS

No Rights history available